Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. META
6. MU
7. BLZE
8. PRIM
9. ACN
10. NVDA

Go back to Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
(NASDAQ: LTRN) Delayed: 3.83 -0.05 (1.29%)
Previous Close $3.88    52 Week High $ 
Open $3.76    52 Week Low $ 
Day High $3.88    P/E N/A 
Day Low $3.76    EPS $ 
Volume 58,544